SCHEMBL13846361

SCHEMBL13846361

NCC(C1CCOCC1)n1cc(-c2ccnc(Nc3ccc(C(=O)N4CC[C@@H](O)C4)cc3)n2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 3/20 0.43
▸ CDK2 P24941 3/20 0.43
▸ JAK2 O60674 7/20 0.43
▸ CCNK O75909 3/20 0.41
▸ CDK12 Q9NYV4 3/20 0.41
▸ JAK3 P52333 6/20 0.41
▸ JAK1 P23458 3/20 0.41
▸ TYK2 P29597 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ NCOR1 O75376 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ IKBKB O14920 4/20 0.40
▸ CHUK O15111 4/20 0.40
▸ IKBKG Q9Y6K9 4/20 0.40
▸ ACVR1 Q04771 2/20 0.40
▸ ATR Q13535 1/20 0.40
▸ PLK4 O00444 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13846262 0.96 JAK2 (0.44) CDK1CDK2JAK2JAK3JAK1
SCHEMBL13846212 0.92 JAK2 (0.48) CDK1CDK2JAK2JAK3JAK1
SCHEMBL3709989 0.91 JAK2 (0.45) CDK1CDK2JAK2JAK3JAK1
SCHEMBL13846365 0.90 JAK2 (0.43) CDK1CDK2JAK2CCNKCDK12
SCHEMBL13846272 0.90 CDK1 (0.43) CDK1CDK2JAK2CCNKCDK12
SCHEMBL13846266 0.89 JAK2 (0.44) CDK2JAK2JAK3JAK1TYK2
SCHEMBL13595268 0.89 IKBKB (0.44) CDK1CDK2JAK2CCNKCDK12
SCHEMBL3719159 0.86 JAK2 (0.46) CDK2JAK2JAK3JAK1TYK2
SCHEMBL4408483 0.86 CDK2 (0.47) CDK1CDK2JAK2CCNKCDK12
SCHEMBL2358934 0.86 CDK2 (0.47) CDK1CDK2JAK2CCNKCDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064835-A1 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-05-22 — — WO disclosed
Send feedback